UnitedHealth Slips 3% as TPG Buys Into Florida WellMed Clinics Ahead of Guidance Reaffirmation

UnitedHealth Slips 3% as TPG Buys Into Florida WellMed Clinics Ahead of Guidance Reaffirmation

David Moadel

Wed, September 9, 2026 at 5:40 PM GMT+3 5 min read

Quick Read

• TPG bought into UNH's Florida WellMed clinics, with CFO DeVeydt calling it a growth partnership rather than a capital raise.

• XLV dropped just 0.4% and peers ELV and HUM held steady, confirming the selloff is UNH-specific, not a broader healthcare story.

• UNH management plans to reaffirm 2026 adjusted EPS in the range of $19.50 to $20.00 and $24 billion operating cash flow at a Wells Fargo conference today.

• Just released. Our analysts combed the entire stock market and named the ten best stocks to buy right now, and UnitedHealth Group didn't make the cut. Enter your email to see the names that beat UNH. The report is free. Enter your email and see if any of your stocks made the cut.

UnitedHealth Group (NYSE:UNH) stock is down 3% to $388.58 in early Wednesday trading after Bloomberg reported the company sold an interest in part of its Florida WellMed primary-care clinics. The 3% slide comes even as UnitedHealth stock is still up 15% year to date, and it lands hours before management is set to reaffirm full-year 2026 financial guidance at an investor conference, according to UnitedHealth Group.

TPG (NASDAQ:TPG) is the buyer. The Fort Worth alternative asset manager ended Q2 2026 with $326.8 billion in assets under management and $76.2 billion in available capital, and its Capital and Healthcare Partners platforms have been active in senior-care buyouts.

WellMed sits inside Optum Health, the value-based care unit whose stumbles drove UnitedHealth's ongoing turnaround. The reaction today looks company-specific rather than sector-wide, and that framing matters for anyone reading through from UnitedHealth into the broader managed-care group.

Selling a Piece of the Problem Child

Bloomberg reported Tuesday evening that UnitedHealth sold an interest in some of its Optum Health operations in Florida to TPG, centered on WellMed's senior primary-care clinics. Terms weren't disclosed, which leaves investors valuing a transaction with no headline dollar figure attached to it.

Free Report, Just Released

Why Didn't UNH Make The Top 10 List?

24/7 Wall St has helped investors make money for over two decades, and our top analysts just finished ranking the definitive Top 10 Stocks To Buy Now. Not the ten biggest companies. Not the ten everyone is arguing about. The ten best stocks to buy right now.

And UNH didn't make the cut!

The report is free, and you can see why we think each stock is a top investment today.

Enter Your Email and See the Ten →

Chief Financial Officer Wayne DeVeydt told Bloomberg, "We didn't need the dollars, we have the dollars to invest, but we needed the focus and somebody that could actually work with us locally." He described the arrangement as a way to grow the clinic footprint faster than UnitedHealth could on its own while it executes a wider reset.

DeVeydt also told the outlet that Optum Health margins will reach 2% this year, ahead of prior expectations, and he guided to 4% next year. That trajectory matters because Optum Health was the source of last year's disappointing profit and the reason the company replaced its chief executive and other senior leaders.

UnitedHealth reported Optum Health revenue of $23.47 billion in Q2 2026, down 5% year over year (YoY) as the unit shed 700,000 value-based care patients. The WellMed carve-in gives Optum a well-capitalized operating partner and hands TPG a foothold in Medicare-focused primary care during a stretch when the sector's economics remain contested.

Sector Barely Flinches

The Health Care Select Sector SPDR ETF (NYSEARCA:XLV) is down 0.4% to $166.44, a fraction of UnitedHealth's move and a sign the story isn't reading as a broader healthcare selloff. UnitedHealth is a top-five weight in the fund at 6.57% of net assets, so a heavier sector drop would be showing up if the news were spilling into the group.

The SPDR S&P 500 ETF Trust (NYSEARCA:SPY) is down 0.35% to $763.31, so the broad tape is merely soft. Managed-care peers Elevance Health (NYSE:ELV), Cigna (NYSE:CI), and Humana (NYSE:HUM) aren't posting a matching drop, which reinforces that today's move is UnitedHealth-specific.

The tension is philosophical. A turnaround company is selling a slice of the exact division that caused the damage, and readers can view that as discipline or as retreat. Without transaction terms, both interpretations have room to breathe.

What to Watch

DeVeydt said UnitedHealth expects to reaffirm its financial guidance at an investor conference hosted by Wells Fargo (NYSE:WFC). That reaffirmation is the more meaningful near-term catalyst, since the July update lifted UnitedHealth's full-year adjusted EPS guidance to $19.50 to $20 and raised the company's operating cash flow outlook to $24 billion.

Analyst consensus for UnitedHealth's full-year 2026 adjusted EPS sits at $19.81, inside management's raised range, and the 2027 consensus sits at $22.44. A clean reaffirmation would keep those numbers intact, while any hedging language on Optum Health could reopen the debate the WellMed deal is trying to settle.

Investors could look for signs that UnitedHealth's management ties the WellMed partnership to specific clinic growth targets or Optum margin milestones on stage. Position sizing on one's UnitedHealth stock exposure may deserve a fresh look given today's gap between the stock and its sector fund.

Got $1,000? Before You Buy UNH, Read This

If you have cash sitting in your account right now, give this two minutes. After more than two decades of helping investors beat the market, our top analysts at 24/7 Wall St. put together a definitive report on the Top 10 Stocks To Buy Today. And UNH wasn't one of them.

They combed the entire market. It's not 10 ideas, not 10 stocks everyone is talking about, it's what their research points to as the 10 best stocks to buy right now, and it's free. Read more here and see which stocks made the list -->>

Contact editorial@247wallst.com for any questions or corrections.